Repeating platinum/bevacizumab in recurrent or progressive cervical cancer yields marginal survival benefits
Author:
Publisher
Elsevier BV
Subject
Obstetrics and Gynecology,Oncology
Reference15 articles.
1. HPV vaccines – a review of the first decade;Harper;Gynecol. Oncol.,2017
2. Evaluation and impact of residual disease in locally advanced cervical cancer after concurrent chemoradiation therapy: Results of a multicenter study;Hequet;Eur. J. Surg. Oncol.,2013
3. Genetic basis for PD-L1 expression in squamous cell carcinomas of the cervix and vulva;Howitt;JAMA Oncol.,2016
4. Unexpected long-term survival without evidence of disease after salvage chemotherapy for recurrent metastatic cervical cancer: a case series;Khoury-Collado;Gynecol. Oncol.,2007
5. Long HJ, 3rd, Bundy BN, Grendys EC, Jr., Benda JA, McMeekin DS, Sorosky J, et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study. J. Clin. Oncol. 2005;23(21):4626–33.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recent Therapeutic Advances in Gynecologic Oncology: A Review;Cancers;2024-02-13
2. BYL719 (alpelisib) for the treatment of PIK3CA-mutated, recurrent/advanced cervical cancer;Tumori Journal;2022-03-20
3. Patient characteristics, treatment patterns, and clinical outcomes among patients with previously treated recurrent or metastatic cervical cancer: A community oncology-based analysis;Gynecologic Oncology;2021-05
4. Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework;British Journal of Cancer;2021-04-13
5. High neutrophil‐to‐lymphocyte ratio is a predictor of short‐term survival for patients with recurrent cervical cancer after radiation‐based therapy;Journal of Obstetrics and Gynaecology Research;2021-02-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3